bluebird bio
BLUE
#9794
Rank
โ‚น4.46 B
Marketcap
โ‚น455.46
Share price
0.00%
Change (1 day)
-74.21%
Change (1 year)

Earnings for bluebird bio (BLUE)

Earnings in 2025 (TTM): -โ‚น16.82 Billion

According to bluebird bio 's latest financial reports the company's current earnings are โ‚น0.10 Billion. In 2024 the company made an earning of -โ‚น22.06 Billion a decrease over its 2023 earnings that were of -โ‚น20.14 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for bluebird bio from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น16.82 Billion-23.75%
2024 -โ‚น22.06 Billion9.52%
2023 -โ‚น20.14 Billion-17.54%
2022 -โ‚น24.42 Billion-18.85%
2021 -โ‚น30.1 Billion-46.87%
2020 -โ‚น56.64 Billion-21.79%
2019 -โ‚น72.42 Billion42.26%
2018 -โ‚น50.91 Billion65.59%
2017 -โ‚น30.74 Billion27%
2016 -โ‚น24.21 Billion58.42%
2015 -โ‚น15.28 Billion175.54%
2014 -โ‚น5.55 Billion138.96%
2013 -โ‚น2.33 Billion6.98%
2012 -โ‚น2.17 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
โ‚น833.95 B-4,654.41%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น2.115 T-11,655.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-โ‚น10 Billion-45.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-โ‚น23.42 Billion 27.86%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-โ‚น2.71 Billion-85.24%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น62.24 B-439.96%๐Ÿ‡บ๐Ÿ‡ธ USA